FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093355387> ?p ?o ?g. }

• W2093355387 endingPage "28" @default.
• W2093355387 startingPage "21" @default.
• W2093355387 abstract "Using polymerase chain reaction (PCR) based techniques, we have identified individuals in the ECTIM study of myocardial infarction survivors (cases) and healthy matched controls who are carriers for a mutation of the gene for lipoprotein lipase (LPL) which alters amino acid 9 from aspartic acid to asparagine (LPL-D9N). The frequency of carriers in the cases from Belfast and France (3 separate centres) was 2.5 and 3.7%, respectively (mean 3.3%, 95% CI 1.9-4.7) and in the controls 2.0 and 2.9%, respectively (mean 2.7%, 95% CI 1.6-3.8%), but this difference was not statistically significant. In the cases, carriers of the allele for LPL-N9 had higher levels of several plasma lipid traits including total triglycerides (TG) (30%), very low density lipoprotein (VLDL) cholesterol (19%), apo E (24%), apo C-III (17%), lipoprotein particles (Lp) containing both apo E and apo B (LpE:B) (32%), and particles containing both apo C-III and apo B (LpCIII:B) (39%), and this effect was consistent in cases both from Belfast and from the French centres combined. By contrast, in the controls there were no differences in any lipid trait between carriers and non-carriers of the mutation that was consistent between the French centres and Belfast. There were no significant differences in the levels of any measured factor between cases and controls that could explain the different effect on plasma lipid traits associated with the mutation. However, compared to the non-carriers, in both cases and controls who carried the mutation, plasma TG concentrations were higher in those whose body mass index (BMI) was above the mean of the sample (26.0 kg/m2), with statistically significant interaction seen between BMI and genotype and levels of apo C-III, and lipoprotein particles containing both apo C-III and apo B (P < 0.02). The data suggest that carriers for the LPL-N9 mutation have a mild genetic predisposition to developing hyperlipidaemia and an atherogenic lipid profile, but that this requires the presence of other genetic or environmental factors for full expression, one of which appears to be increasing obesity." @default.
• W2093355387 created "2016-06-24" @default.
• W2093355387 creator A5000649681 @default.
• W2093355387 creator A5005485661 @default.
• W2093355387 creator A5007875460 @default.
• W2093355387 creator A5010213400 @default.
• W2093355387 creator A5021254466 @default.
• W2093355387 creator A5027162485 @default.
• W2093355387 creator A5044262070 @default.
• W2093355387 creator A5045448492 @default.
• W2093355387 creator A5049250255 @default.
• W2093355387 creator A5064235722 @default.
• W2093355387 creator A5084502500 @default.
• W2093355387 creator A5084645948 @default.
• W2093355387 date "1996-04-01" @default.
• W2093355387 modified "2023-10-14" @default.
• W2093355387 title "Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study" @default.
• W2093355387 cites W1537149240 @default.
• W2093355387 cites W1982597172 @default.
• W2093355387 cites W2004282447 @default.
• W2093355387 cites W2005337337 @default.
• W2093355387 cites W2019168651 @default.
• W2093355387 cites W2025139995 @default.
• W2093355387 cites W2043600435 @default.
• W2093355387 cites W2043666603 @default.
• W2093355387 cites W2049695571 @default.
• W2093355387 cites W2050971515 @default.
• W2093355387 cites W2070547707 @default.
• W2093355387 cites W2088233943 @default.
• W2093355387 cites W2095045276 @default.
• W2093355387 cites W2109324726 @default.
• W2093355387 cites W2110189202 @default.
• W2093355387 cites W2113784056 @default.
• W2093355387 cites W2118094114 @default.
• W2093355387 cites W2148086780 @default.
• W2093355387 cites W2154006542 @default.
• W2093355387 cites W2158360813 @default.
• W2093355387 cites W2994215404 @default.
• W2093355387 doi "https://doi.org/10.1016/0021-9150(95)05736-6" @default.
• W2093355387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8724108" @default.
• W2093355387 hasPublicationYear "1996" @default.
• W2093355387 type Work @default.
• W2093355387 sameAs 2093355387 @default.
• W2093355387 citedByCount "51" @default.
• W2093355387 countsByYear W20933553872012 @default.
• W2093355387 countsByYear W20933553872013 @default.
• W2093355387 countsByYear W20933553872016 @default.
• W2093355387 countsByYear W20933553872019 @default.
• W2093355387 countsByYear W20933553872020 @default.
• W2093355387 crossrefType "journal-article" @default.
• W2093355387 hasAuthorship W2093355387A5000649681 @default.
• W2093355387 hasAuthorship W2093355387A5005485661 @default.
• W2093355387 hasAuthorship W2093355387A5007875460 @default.
• W2093355387 hasAuthorship W2093355387A5010213400 @default.
• W2093355387 hasAuthorship W2093355387A5021254466 @default.
• W2093355387 hasAuthorship W2093355387A5027162485 @default.
• W2093355387 hasAuthorship W2093355387A5044262070 @default.
• W2093355387 hasAuthorship W2093355387A5045448492 @default.
• W2093355387 hasAuthorship W2093355387A5049250255 @default.
• W2093355387 hasAuthorship W2093355387A5064235722 @default.
• W2093355387 hasAuthorship W2093355387A5084502500 @default.
• W2093355387 hasAuthorship W2093355387A5084645948 @default.
• W2093355387 hasConcept C104317684 @default.
• W2093355387 hasConcept C126322002 @default.
• W2093355387 hasConcept C134018914 @default.
• W2093355387 hasConcept C171089720 @default.
• W2093355387 hasConcept C180754005 @default.
• W2093355387 hasConcept C185592680 @default.
• W2093355387 hasConcept C2778163477 @default.
• W2093355387 hasConcept C2779134260 @default.
• W2093355387 hasConcept C2780072125 @default.
• W2093355387 hasConcept C501734568 @default.
• W2093355387 hasConcept C54355233 @default.
• W2093355387 hasConcept C57089818 @default.
• W2093355387 hasConcept C62746215 @default.
• W2093355387 hasConcept C71924100 @default.
• W2093355387 hasConcept C8243546 @default.
• W2093355387 hasConcept C86803240 @default.
• W2093355387 hasConcept C94879076 @default.
• W2093355387 hasConceptScore W2093355387C104317684 @default.
• W2093355387 hasConceptScore W2093355387C126322002 @default.
• W2093355387 hasConceptScore W2093355387C134018914 @default.
• W2093355387 hasConceptScore W2093355387C171089720 @default.
• W2093355387 hasConceptScore W2093355387C180754005 @default.
• W2093355387 hasConceptScore W2093355387C185592680 @default.
• W2093355387 hasConceptScore W2093355387C2778163477 @default.
• W2093355387 hasConceptScore W2093355387C2779134260 @default.
• W2093355387 hasConceptScore W2093355387C2780072125 @default.
• W2093355387 hasConceptScore W2093355387C501734568 @default.
• W2093355387 hasConceptScore W2093355387C54355233 @default.
• W2093355387 hasConceptScore W2093355387C57089818 @default.
• W2093355387 hasConceptScore W2093355387C62746215 @default.
• W2093355387 hasConceptScore W2093355387C71924100 @default.
• W2093355387 hasConceptScore W2093355387C8243546 @default.
• W2093355387 hasConceptScore W2093355387C86803240 @default.
• W2093355387 hasConceptScore W2093355387C94879076 @default.
• W2093355387 hasIssue "1" @default.
• W2093355387 hasLocation W20933553871 @default.

• next